Phosphate Therapeutics raises EUR 10.5 million

Phosphate Therapeutics Ltd. (Newcastle, U.K.) raised EUR 10.5 million ($13.9 million) from Inventages Venture Capital and received exclusive, worldwide rights to phosphate binder PT20 from U.K.'s Medical Research Council. MRC received an undisclosed equity stake and is eligible for milestones, plus single-digit royalties. ...